FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Allergic Conjunctivitis Market Overview:

According to FutureWise analysis the market for Allergic Conjunctivitis in 2023 is US$ 2.12 billion, and is expected to reach US$ 3.01 billion by 2031 at a CAGR of 4.50%.

Allergic conjunctivitis is an eye condition that can happen to anyone at any time, but it's more common during certain seasons. Outdoor allergens such as pollen, grass, or trees usually trigger seasonal allergies, while indoor allergens like pet dander, dust, or mold can cause perennial allergies. Upon exposure to allergens, the immune system of an individual initiates the release of histamine, leading to conjunctival inflammation. The conjunctiva refers to the delicate membrane that covers the sclera, or the white part of the eye.

Symptoms of allergic conjunctivitis can vary in severity and can include redness, itching, swelling, and burning sensations in the eyes. In some cases, individuals may also experience watery eyes, blurred vision, and sensitivity to light. To diagnose this condition, an eye exam and allergy testing may be required. Identifying the specific allergens responsible for triggering the immune response is made possible through allergy testing. This allows healthcare professionals to offer more precise treatment options to their patients. Effective treatment methods for allergic conjunctivitis can include avoiding allergens, using medications like eye drops or antihistamines, and applying cold compresses.

FutureWise Market Research has published a report that provides an insightful analysis of allergic conjunctivitis market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that allergic conjunctivitis market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

Major players included in the Allergic Conjunctivitis Market:

Aciex Therapeutics
Alcon/Novartis
Sun Pharma Advanced Research Company
Sirion Therapeutics
Boehringer Ingelheim
Atopix Therapeutics
Laila Pharmaceuticals
Laboratoires Thea S.A.
Auven Therapeutics
Ocular Therapeutix

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Allergic Conjunctivitis Market:

In February 2021, Alcon has announced that its eye allergy solution, the Pataday Once Daily Relief Extra Strength, is now available for purchase in both physical and online stores across the US, after obtaining FDA approval in 2020. The drug has been cleared by the FDA for over-the-counter sale.

The global market for allergic conjunctivitis is steadily growing due to the increasing prevalence of allergies and allergic diseases worldwide. Factors like pollution, lifestyle changes, and higher exposure to allergens are all contributing to the rise in allergic conjunctivitis cases. Despite the challenge posed by over-the-counter medications and self-care practices, prescription-based treatments remain a trustworthy option for managing this condition. The market is presenting growth opportunities with the introduction of biologics and targeted therapies that demonstrate superior effectiveness and fewer side effects. Furthermore, the integration of digital healthcare technologies like telemedicine and remote patient monitoring is offering a convenient and efficient solution for managing allergic conjunctivitis. The market's future potential for growth hinges on innovative therapies and the continued integration of digital healthcare solutions. It is crucial to emphasize that effective treatment options, timely diagnosis, and management are essential in managing this condition, and awareness of these factors must remain high.

Allergic Conjunctivitis Market Segmentation:

By Disease Type

Seasonal Allergic Conjunctivitis
Perennial Allergic Conjunctivitis
Giant Papillary Conjunctivitis
Vernal Kerato Conjunctivitis
Atopic Kerato Conjunctivitis

By Treatment Type

Antihistamines
Decongestant
Mast Cell Stabilizers
Olopatadine
Epinastine
Nonsteroidal Anti-Inflammatory Drugs
Immunotherapy
Ointments
Others

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. North America is projected to dominate the global allergic conjunctivitis market during the forecast period, driven by widespread awareness, high disease prevalence, and the presence of major players launching advanced drugs. Europe is expected to be the second-largest market, with a rising patient population and increased usage of sophisticated drugs. In the United Kingdom, seasonal allergic conjunctivitis (SAC) is prevalent, affecting 10%-15% of the population. As a result of the convergence of all of these variables, North America and Europe will emerge as the most promising, high-growth market in the projection period.

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Allergic Conjunctivitis Market By Disease Type, By Treatment Type and By Region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1 . Years Considered for the Study
  3.2 . Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1 . Secondary Data
  1.1.1 . Key Data from Secondary Sources
  1.2 . Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Allergic Conjunctivitis Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Allergic Conjunctivitis Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Allergic Conjunctivitis Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Allergic Conjunctivitis Market, By Disease Type Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Seasonal Allergic Conjunctivitis
  2. Perennial Allergic Conjunctivitis
  3. Giant Papillary Conjunctivitis
  4. Vernal Kerato Conjunctivitis
  5. Atopic Kerato Conjunctivitis
8. Allergic Conjunctivitis Market, By Treatment Type Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Antihistamines
  2. Decongestant
  3. Mast Cell Stabilizers
  4. Olopatadine
  5. Epinastine
  6. Nonsteroidal Anti-Inflammatory Drugs
  7. Immunotherapy
  8. Ointments
  9. Others
9. North America Allergic Conjunctivitis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
10. Latin America Allergic Conjunctivitis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
11. Europe Allergic Conjunctivitis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
12. Asia Pacific Allergic Conjunctivitis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
13. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. GCC
  2.2. Israel
  2.3. South Africa
  2.4. Rest of MEA
  3. Market Size (USD Million) Forecast for MEA 2023-2031
14. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. Aciex Therapeutics
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Alcon/Novartis
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Sun Pharma Advanced Research Company
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. Sirion Therapeutics
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. Boehringer Ingelheim
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Atopix Therapeutics
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Laila Pharmaceuticals
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Laboratoires Thea S.A.
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Auven Therapeutics
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Ocular Therapeutix, Inc.
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
16. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by administrations
  5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients